{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:22:02Z","timestamp":1791400922929,"version":"4.3.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the association between D-dimer and cardiovascular diseases outcomes in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single-center retrospective cohort study which was performed in a population who had health examinations between 2010 and 2015 in Jiangxi Provincial People's Hospital. All adult patients who were diagnosed with type 2 diabetes were screened. The cardiovascular diseases events were defined as all-cause mortality, new cardiovascular diseases incidence (acute myocardial infarction, unstable angina, stroke), or cardiovascular mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age was 59.6\u00a0years; 50.1% of participants were women; D-dimer was significantly associated with endpoint events. After multivariable adjustment for form of treatments and traditional risk factors, the odds ratio was 3.62 (95% CI 2.07\u20136.03) for the highest quartile of D-dimer with the lowest quartile as reference. Meanwhile, higher D-dimer levels were associated with a significant and independent higher risk of cause-specific cardiovascular disease events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High plasma concentrations of D-dimer were associated with increased risk of cardiovascular diseases events in patients with type 2 diabetes, even after adjusting for cardiovascular risk factors and form of treatments. Measurement of D-dimer may lead to a practical improvement in the current risk stratification criteria for patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-022-02531-x","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:38:34Z","timestamp":1646383114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus"],"prefix":"10.1186","volume":"22","author":[{"given":"Lan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"issue":"13","key":"2531_CR2","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878\u201387.","journal-title":"Blood"},{"issue":"7","key":"2531_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.117.029901","volume":"138","author":"J Simes","year":"2018","unstructured":"Simes J, Robledo KP, White HD, et al. D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study. Circulation. 2018;138(7):712\u201323.","journal-title":"Circulation"},{"key":"2531_CR4","doi-asserted-by":"crossref","first-page":"204062232090430","DOI":"10.1177\/2040622320904302","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao X, Li J, Tang X, et al. D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention. Ther Adv Chronic Dis. 2020;11:2040622320904302.","journal-title":"Ther Adv Chronic Dis"},{"issue":"16","key":"2531_CR5","doi-asserted-by":"publisher","first-page":"e19724","DOI":"10.1097\/MD.0000000000019724","volume":"99","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Xue Y, Shen J, Zhou W, Wen Y, Luo S. Predictive values of D-dimer for the long-term prognosis of acute ST-segment elevation infarction: A retrospective study in southwestern China. Medicine (Baltimore). 2020;99(16):e19724.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"2531_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"issue":"19","key":"2531_CR7","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","volume":"70","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2531_CR8","first-page":"434","volume":"26","author":"ZF Long","year":"2001","unstructured":"Long ZF, Qu GY, Xu M. Relationship between the level of plasma D-dimer and diabetic microangiopathy. Hunan Yi Ke Da Xue Xue Bao. 2001;26(5):434\u20136.","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"issue":"3","key":"2531_CR9","first-page":"657","volume":"9","author":"MA El Asrar","year":"2012","unstructured":"El Asrar MA, Adly AA, El Hadidy ES, Abdelwahab MA. D-dimer levels in type 1 and type 2 diabetic children and adolescents; relation to microvascular complications and dyslipidemia \u201cown data and review.\u201d Pediatr Endocrinol Rev. 2012;9(3):657\u201368.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"1","key":"2531_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11239-007-0155-0","volume":"27","author":"I Wakabayashi","year":"2009","unstructured":"Wakabayashi I, Masuda H. Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus. J Thromb Thrombolysis. 2009;27(1):29\u201335.","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2531_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1076029609334626","volume":"16","author":"AL Soares","year":"2010","unstructured":"Soares AL, Ros\u00e1rio PW, Borges MA, Sousa MO, Fernandes AP, Md C. PAI-1 and D-dimer in type 2 diabetic women with asymptomatic macrovascular disease assessed by carotid Doppler. Clin Appl Thromb Hemost. 2010;16(2):204\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"2531_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","volume":"30","author":"CP Domingueti","year":"2016","unstructured":"Domingueti CP, Dusse LM, Md C, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat. 2016;30(4):738\u201345.","journal-title":"J Diabetes Complicat"},{"issue":"9","key":"2531_CR13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3324\/haematol.2012.083410","volume":"98","author":"A Di Castelnuovo","year":"2013","unstructured":"Di Castelnuovo A, de Curtis A, Costanzo S, et al. Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica. 2013;98(9):1476\u201380.","journal-title":"Haematologica"},{"issue":"4","key":"2531_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1479164110383723","volume":"7","author":"SH Alzahrani","year":"2010","unstructured":"Alzahrani SH, Ajjan RA. Coagulation and fibrinolysis in diabetes. Diab Vasc Dis Res. 2010;7(4):260\u201373.","journal-title":"Diab Vasc Dis Res"},{"issue":"6","key":"2531_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCULATIONAHA.110.014860","volume":"124","author":"BE Sobel","year":"2011","unstructured":"Sobel BE, Hardison RM, Genuth S, et al. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2011;124(6):695\u2013703.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02531-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02531-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02531-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:44:06Z","timestamp":1646383446000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02531-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02531-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"25 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols of this study were approved by the institutional Ethics Research Committee of Jiangxi Provincial People\u2019s Hospital. The study was performed according to the declaration of Helsinki. Written informed consent for this study was also approved by the Jiangxi Provincial People\u2019s Hospital Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}